• Risk-sharing Alliance progresses on-chip Models for IBD and HBV
    Image Credit: Pexels

News & Views

Risk-sharing Alliance progresses on-chip Models for IBD and HBV

Jul 24 2021

Organ-on-chip-based research and technology company MIMETAS (Leiden), is collaborating with pharmaceutical business Roche, to develop human disease models to characterise novel compounds in inflammatory bowel disease (IBD) and hepatitis B virus infections (HBV). Under the terms of the agreement, MIMETAS is eligible to receive an upfront payment and milestone payments from Roche.

The Netherlands-based company will be responsible for developing tissue-based disease models and assays using its OrganoPlate, proprietary organ-on-chip platform that increases predictability of biomarkers and reduces animal use in scientific testing. Along with gaining access to the platform technology and results developed under the collaboration, Roche will also receive an option to exclusively license specific disease models and assays for use in drug discovery.

"This exciting collaboration enables our research and early development group to apply state-of-the-art organ-on-a-chip technology in the modeling of IBD and HBV. These models have the potential to improve our understanding of disease biology and transform our drug discovery process," said James Sabry, Global Head, Roche Pharma Partnering.

"The collaboration with Roche leverages our ongoing focus on developing predictive, phenotypic models, preceded by numerous successful projects over the last eight years," said Jos Joore, CEO of MIMETAS. "We will leverage our disease modeling expertise in our world-leading OrganoPlate platform to gain novel insights in IBD and HBV. Working together with the outstanding Roche team, we hope to make a difference in the lives of patients."

Further information online


Digital Edition

Labmate UK & Ireland 49.2 - March 2024

March 2024

In This Edition Articles - Choosing the right LIMS for your lab: Four key considerations - Pay increases to continue but staff focus on security and training - Building a global culture of...

View all digital editions

Events

Making Pharmaceuticals

Mar 26 2024 Milan, Italy

FORUM LABO LYON

Mar 27 2024 Lyon, France

Microbiology Society Annual Conference 2024

Apr 08 2024 Edinburgh 2024

analytica 2024

Apr 09 2024 Munich, Germany

ChemBio Finland 2024

Apr 10 2024 Helsinki, Finland

View all events